STAAR Surgical ICL Sales Up 46%; Company Raises Outlook for Full Year 2018
MONROVIA, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended September 28, 2018. Third Quarter 2018 Overview Net Sales of $31.8 Million Up 35% from the Prior Year Quarter ICL Sales Up 46% and Units Up 56% from the Prior Year Quarter Gross Margin at 75.1% of Sales from 71.8% of Sales in the Prior Year Quarter Ea